← Therapeutics
Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry-results+publication
University of Iowa zinc tinnitus trial
Also known as: Zinc sulfate, Zinc to Treat Tinnitus in the Elderly, NCT00683644
Institution-led study
Sponsor / Institution
Institution-led study
Program Type
Therapeutic
Modality
Small Molecule
Stage
Phase 2
Status
Completed
Target Gene
—
Route / Mode
Oral capsule
Confidence
86%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-09
Geography
United States
Population
adult, older-adult, tinnitus
Trial IDs
1
Mechanism
Completed randomized placebo-controlled crossover trial testing oral zinc sulfate, 50 mg elemental zinc daily, for tinnitus in older adults.
Indications
Notes
Corrected from a generic supplement row to the completed University of Iowa/Tinnitus Research Initiative crossover trial. ClinicalTrials.gov posted results and the publication reports the elderly tinnitus zinc trial; the record should remain historical and study-level rather than being presented as an active tinnitus therapy program.
Evidence & Sources
2 structured sourcesKey Events
Clinical Trials (1)
Data Checks
institution-led-studypublished-resultshistorical-completed-studystudy-level-not-standalone-product
Related Programs
PEDMARK by Fennec Pharmaceuticals
Company: Fennec Pharmaceuticals · Small Molecule · Marketed
SENS-401 (Arazasetron) by Sensorion
Company: Sensorion · Small Molecule · Phase 2
AC102 by AudioCure Pharma
Company: AudioCure Pharma · Small Molecule · Phase 2
SPI-1005 by Sound Pharmaceuticals
Company: Sound Pharmaceuticals · Small Molecule · Phase 3
ACOU085 by Acousia Therapeutics
Company: Acousia Therapeutics GmbH · Small Molecule · Phase 2
CIL001 (Paliroden) by Cilcare
Company: Cilcare SAS · Small Molecule · Phase 1/2